Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. uri icon

authors

  • Raychaudhuri, Ruben
  • Hannochka, Andrii
  • Conrad, Nathan
  • Kahugu, Martha
  • Panlasigui, Patrick
  • Haffner, Michael C
  • Hsieh, Andrew C
  • Lam, Hung-Ming
  • Vakar-Lopez, Funda
  • Yezefski, Todd
  • Schweizer, Michael T
  • Khaki, Ali Raza
  • Montgomery, Robert B
  • Yu, Evan Y
  • Dash, Atreya
  • Sarah P. Psutka MD MS
  • Lin, Daniel W
  • Schade, George R
  • Gore, John L
  • Wright, Jonathan L
  • Grivas, Petros
  • Redman, Mary W
  • Baker, Kelsey K
  • Ng, Kevin
  • Chen, Xueyan
  • Mao, Jenny
  • Woo, Brianna
  • Lin, Aaron

publication date

  • August 5, 2025